Sign in to view content

BVA Analysis of Low- or High-Dose MCO-010 Optogenetics Therapy for Retinitis Pigmentosa: First Time 100-Week TOPLINE Results From a Phase 2b/3 Clinical trial (RESTORE)

Michael A. Singer, MD

Video
Published 2024

Related

Retinitis Pigmentosa
Avris Romario Diparaja Siahaan
Retina Image Bank: Images of the Week
2015
Episode 3: 5-year Results of Argus II Retina Prosthesi with Dr. Rob Devenyi
Keyvan Koushan, MD, FRCSC
Member Podcasts
2017
Intravitreal Injection of Allogeneic Human Retinal Progenitor Cells for Treatment of Retinitis Pigmentosa: Results from the Phase 2b Trial
Anthony Joseph, MD
Annual Meeting Talks
2020

Category: Hereditary Retinal Disease & Genetics

See more